EUCROF encourages the initiatives of its Members to form Working Groups (WGs), which represent an open area of discussion on specific areas of interest for Members. Any (Associate) Member can contribute to the WGs by nominating a representative. The WGs meet regularly through TCs and/or face to face meetings. In accordance to the focus of each WG, they are intended to become counterpart/stakeholders for Regulatory Authorities, Industry, Academia and Patients' Associations, write papers in Scientific Journals, actively participate to Congresses/Conferences, thus representing the position and the interests of EUCROF.
Antoinette VAN DIJK
Switzerland
Phone: +41 79 51 17 359
Mobile: +39 335 56083680
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair: Antoinette van Dijk
WG Members – Vivienne van de Walle (PT&R - The Netherlands), Isabelle Coupienne (Researchlink - Belgium), Ornela Cullufe (CVBF - Albania), Claudine Richon (Popsicube-fovea - France), Sebnem Yasarogullari (MENE Research - Turkey).
Dagmar CHASE
BVMA
Phone: +49 89 92 92 87 0
Fax: +49 89 92 92 87 50
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
The EUCROF Clinical Trials Legislation Working Group (CTL WG) is aimed to represent European CROs when input is sought from stakeholders by legislators (e.g., EMA, EU Commission) or international organisations (e.g., ICH, WHO) in the context of new provisions for clinical trials. It is crucial that CROs provide their perspectives and opinions as more than 60% of clinical trials are handled by CROs. The delegation of sponsor duties and functions to CROs is important to be taken into account when legal regulations and guidance documents are developed. EUCROF does not miss this chance and continuously participates in the consultation rounds offered by legislators and/or international organisations.
The CTL WG is in operation since more than a decade and has given input to numerous documents with latest activities on the “Management of Clinical Trials under COVID-19 Pandemic”.
It is our mission to effectively use the voice we have through the European CRO Federation.
We are looking forward to continue our active involvement in the development of Clinical Trials documents.
WG Chair: Dagmar Chase
WG Members – Ulrike Lorch (Richmond Pharmacology - UK), Simon Lee (Quotient - UK), Eirini Tsante (Next CRO - Greece), Carmen Masanneck (EastHORN - Czech Republic (Germany)), Maria Moumouri (Next CRO - Greece).
Christophe GOLENVAUX
BeCRO
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Christophe Golenvaux
WG Members – Darina Hrdličková (ACRO-CZ - Czech Republic), Simon Lee (CCRA - UK), Véronique Marty (AFCROs - France) Juraj Gaplovsky (SACROP - Slovenia), Mariangela Lupo (CVBF - Italy), Ignacio Jimenez (Sermes - Spain), Assia Rosati (EUCROF).
Harry Therianos
Medical Director - Coronis Research S.A. (Athens, Greece)
Tel.: (+30)210.87.78.000
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Harry Therianos
WG Members – Maria Bernardo (PPD - Spain), Caridad Fernandez (PPD – Spain), Nadia Zeini (Premier Research - Spain).
Donato BONIFAZI
Chief Executive Officer - Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF, Italy)
Tel.: +39 080 975 1974
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Donato Bonifazi
Harsha Basudev (Parexel - Italy), Simone Bucerius (FGK Clinical Research - Germany), Cristina Florescu (Avantyo Institute of Clinical Research - Romania), Manika Kreka (CVBF – Albania), Marta Lettieri (CVBF - Italy), Mariangela Lupo (CVBF - Italy), Marieke Meulemans (GCP Central - The Netherlands), Ana Stoiković (Optimapharm - Croatia), Katerina Tsagaraki (Coronis Research - Greece), Goran Vesov (Optimapharm - Croatia).
Dolores Pérez Méndez
Sermes CRO, Spain
Phone: +34 608 505 507
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Dolores Pérez Méndez
WG Members – Stefan Siegmund (Convidia - Germany) and Rasid Kamal (PPD - Czech Republic).
The goal of this WG is to identify, examine and provide solutions to the principal issues identified in Advanced Therapy Medical Products development and regulation, in constant dialogue and collaboration with the Industry and European Authorities.
Meeting by teleconference (Monthly/ every two months)
Alexandre Malouvier
Director Global Data Strategy, Digital Health
Dir Tel: +33 (0)1 41 34 45 59
Mobile: + 33 (0)6 14 34 72 31
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair: Alexandre Malouvier
WG Co-chair: Denis Comet
WG Members: Liliana Cunha (Clinical Trial & Consulting - Portugal), Remi Gauchon (France), Klairi Liakou (Turkey), Hubert Mechin (Helsia - France), Georgie Nock (pH Associates – UK), Eleni Politi (Greece), Aize Smink (Julius Clinical - The Netherlands), Dana Vankova (IQVIA - Czech Republic).
Monthly meeting is generally organized through teleconference
Burcu CEHRELI
Head of Clinical Operations ∙ MENE Research
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Direct: +90(262) 678 8867 ext:102
Mobile: +90(507) 812 90 40
Fax: +90(262) 751 28 38
Members
WG Chair – Ayse Burcu Cehreli
WG Members – Antoinette van Dijk (AICRO – Italy), Franz Josef Binmoeller (SyneosHealth – Germany), Laura Michelini (Italy).
Alan Yeomans
Quality Manager
PCG Solutions AB
Mobile : +46 70 540 0299
This email address is being protected from spambots. You need JavaScript enabled to view it.
Co-Chair
Yoani Matsakis
President
TELEMEDICINE TECHNOLOGIES S.A.S.
Mobile: +33 6 85 04 57 21
This email address is being protected from spambots. You need JavaScript enabled to view it.
The group evaluates new technologies that impact the clinical trial environment and evaluates how these can benefit clinical research.
WG Chair – Alan Yeomans
WG Co-chair – Yoani Matsakis
WG Initiator – Yoani Matsakis
WG Members – Thierry Lepoutre (Lambdaplus – Belgium), Michèle Garot (ClinCellence -Belgium), Isabelle Abousahl (Alcoam By Design – France), Sarah Dubray (ICON - France), Ignacio Jimenz (Sermes – Spain), Keith Berelowitz (Richmond Pharmacology – UK) [Mika Lindroos, Finland - eCF; Fiona Maini, UK - eCF; Dagmar Chase, Germany - REG].
Meetings
Webinar meetings are approximately once a month (about 10 times a year).
Face-to-face meetings can be held in conjunction with EUCROF conferences if there is a need.
Martine DEHLINGER-KREMER
BVMA
Phone: +49 911946469 0
Fax: +49 91194646999
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Martine Dehlinger-Kremer
WG Members – Alex Cvetkovic Muntañola (Syneos – Spain), Sofia Romboli (Zeincro Hellas - Greece), Jürgen Schäfer (Conreso GmbH – Germany), Donato Bonifazi (CVBF – Italy), Nira Garty (Perfection-CRO Ltd – Israel), Erik Hamminga (Covance - The Netherlands), Ian Vasicka (Co-Investigator/Advisor - Czech Republic), Nuria Martinez-Alier (IQVIA/Advisor – UK), Pavla Nevolova (EastHORN - Czech Republic).
Marta Manso
This email address is being protected from spambots. You need JavaScript enabled to view it.
Business Development
SERMES CRO
Fostering actual & confident collaboration with patients in clinical research.
WG Members – Marta Manso (Spain), Mariangela Lupo (Italy), Simon Klaasen (The Netherlands), Manika Face Kreka (Albania), Ornela Cullufe (Albania), Hélène Moussu (France).
Webinar meetings on a monthly base.
Face-to-face meetings.
Nicolas TSIAKKAS
Scientific Director
Medwork Pharma Research & Consulting
5, Chiou st., 164 52 Argyroupoli, Athens, Greece
Phone: +30 210 9960971
Fax: +30 210 9969578
Xavier FOURNIE
Corporate Medical Director
Vice-President, Global Medical Affairs - ICON Commercialisation & Outcomes
Phone: +33 (0)4 72 13 66 85
Mobile: +33 (0)6 88 20 00 61
27 rue de la Villette | 69003 LYON | FRANCE
This email address is being protected from spambots. You need JavaScript enabled to view it.
Position EUCROF PV WG as important conduit and as a reference for stakeholders in the EU pharmacovigilance fora
Main objectives:
WG Chair – Nicolas Tsiakkas
WG Co-chair – Xavier Fournie
WG Members – Marco Anelli (Productlife-group – Italy), Zurab Koberidze (FGK-PV – Germany), Essam Ghanem (Vigi-Care – Belgium), Fleming Kjær Jørgensen (Klifo – Denmark).